Atrás
Rango del Día
$72.00
$79.01
Rango de 52 Semanas
$61.96
$138.70
Volumen
224,285
Promedio 50D / 200D
$82.07
/
$90.49
Cierre Anterior
$79.59
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 456.8 | 0.3 |
| P/B | 7.1 | 2.9 |
| ROE % | 2.3 | 3.7 |
| Net Margin % | 2.4 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$130.33
+75.9%
Low: $110.00
High: $150.00
P/E Futuro
169.9
EPS Futuro
$0.47
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
440 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.27
$1.23 – $1.30
|
810 M | 1 |
| FY2029 |
$1.89
$1.83 – $1.94
|
790 M | 1 |
| FY2028 |
$1.59
$0.71 – $2.66
|
720 M | 5 |
Puntos Clave
ROE of 2.30% is below average
Debt/Equity of 0.23 — conservative balance sheet
Generating 15.71M in free cash flow
P/E of 456.82 — premium valuation
Cash machine — converts 210.81% of earnings into free cash flow
Capital efficient — spends only 2.91% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)99.97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
2.30%
ROIC2.04%
Net Margin2.44%
Op. Margin5.25%
Seguridad
Debt / Equity
0.23
Current Ratio11.69
Interest Coverage168.66
Valoración
P/E Ratio
456.82
P/B Ratio7.09
EV/EBITDA188.36
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 99.97% | Revenue Growth (3Y) | 106.24% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 305.11M | Net Income (TTM) | 7.45M |
| ROE | 2.30% | ROA | 1.18% |
| Gross Margin | 68.32% | Operating Margin | 5.25% |
| Net Margin | 2.44% | Free Cash Flow (TTM) | 15.71M |
| ROIC | 2.04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.23 | Current Ratio | 11.69 |
| Interest Coverage | 168.66 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 456.82 | P/B Ratio | 7.09 |
| P/S Ratio | 11.16 | PEG Ratio | -4.71 |
| EV/EBITDA | 188.36 | Dividend Yield | 0.00% |
| Market Cap | 3.41B | Enterprise Value | 3.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 305.11M | 152.58M | 71.73M |
| Net Income | 7.45M | -41.57M | -82.68M |
| EPS (Diluted) | 0.06 | -0.93 | -1.85 |
| Gross Profit | 208.46M | 80.92M | 17.31M |
| Operating Income | 16.02M | -47.15M | -69.50M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 632.65M | 302.06M | 191.68M |
| Total Liabilities | 152.55M | 134.31M | 161.20M |
| Shareholders' Equity | 480.11M | 167.75M | 30.47M |
| Total Debt | 108.90M | 109.38M | 146.35M |
| Cash & Equivalents | 495.98M | 191.48M | 97.27M |
| Current Assets | 560.56M | 227.82M | 115.50M |
| Current Liabilities | 47.96M | 28.39M | 66.80M |